drs. schalper, riess & wainberg discuss #immunotherapy #biomarkers #uscap22 https://bit.ly/3iyowvd
Published Streamed 2 years ago • 207 plays • Length 1:37:34
Download video MP4
Download video MP3
Similar videos
-
1:34:19
drs. schalper, press, tarantino & wainberg discuss #her2, #her3, & #trop2: https://bit.ly/37bh4ek
-
1:05:35
drs. cottrell & sholl discuss #immunotherapy updates at #uscap2023 - https://bit.ly/3mkijyk
-
1:27:54
watch drs. schalper, anders, & patel discuss io updates from #cap21: https://bit.ly/3elivcp
-
59:37
drs. altorki & spicer discuss #nsclc #immunotherapy at #thoracicsummit2022 - https://bit.ly/3bxcsbv
-
56:08
gaining confidence in predicting and assessing response to cancer immunotherapies
-
1:14:51
the present and the future of cancer immunotherapy biomarkers
-
1:25:26
drs. moslehi & johnson discuss #cardioonc at #aha22 - https://bit.ly/3tim0qn
-
1:18
scrna-seq of the immune microenvironment reveals immunotherapy response biomarkers in high-risk smm
-
1:03:39
deep insight into immuno-oncology: immunotherapy pathways, targets, and biomarkers
-
1:12:08
watch dr. baugh & awad, discuss the latest cancer immunotherapy from #acep21: https://bit.ly/3ptzhzh
-
1:11:32
refining best practices in cancer immunotherapy biomarker testing and pathologic response assessment
-
1:01:46
biomarkers, immunotherapies, combinations, and other emerging approaches for lung cancer
-
42:53
biomarkers in cancer immunotherapy: how much do they matter?
-
0:56
dr. antoni ribas on the search for immunotherapy biomarkers in melanoma
-
1:25:15
decoding biomarker testing and targeted therapy in nsclc
-
1:10:20
watch drs broderick & wakelee discuss the latest in nsclc: https://bit.ly/2021-nsclc
-
1:03:55
the nuances of immunotherapy biomarker testing in solid tumors
-
1:01:42
drs. shu & stiles discuss #nsclc at #aats2023 - https://bit.ly/3vg1zva
-
54:59
linking immunotherapy to better outcomes in resectable melanoma
Clip.africa.com - Privacy-policy